GlassScriptPhysician profile
Gary K Adams
NPI 1487772802
$2,480.29
in general payments reported to CMS, 2019-2025
9 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.76 · 2020: $479 · 2021: $1,239 · 2022: $323 · 2023: $211 · 2024: $24.97 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,221.28 | 2020-2025 | Xeomin |
| Amarin Pharma, INC. | $720.56 | 2019-2022 | |
| Abbvie INC. | $208.55 | 2019-2024 | Botox |
| Allergan, INC. | $172.32 | 2019-2022 | |
| Ibsa Pharma INC. | $78.41 | 2020-2021 | |
| Currax Pharmaceuticals LLC | $30.39 | 2022-2025 | Contrave |
| Acella Pharmaceuticals, LLC | $18.71 | 2025 | NP Thyroid 60 |
| Novo Nordisk INC | $15.94 | 2022 | |
| Indivior INC. | $14.13 | 2025 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.